Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer Cells: The Secret Weapon in Dendritic Cell Vaccination Strategies
Catharina H. M. J. Van Elssen, Tammy Oth, Wilfred T.V. Germeraad, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 5, pp. 1095-1103
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Dendritic Cell–Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol, Gerty Schreibelt, Winald R. Gerritsen, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 8, pp. 1897-1906
Open Access | Times Cited: 336
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 276
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner, Miriam E. Friede, Congcong Zhang, et al.
Cytotherapy (2016) Vol. 19, Iss. 2, pp. 235-249
Open Access | Times Cited: 170
Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy
Yuzhu Hu, Wen Nie, Liang Lyu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3295-3312
Closed Access | Times Cited: 17
Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
Andrea Gras Navarro, Andreas T. Björklund, Martha Chekenya
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 151
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
Sébastien Anguille, Evelien Smits, Christian Bryant, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 731-753
Open Access | Times Cited: 143
PD-L1 blockade enhances anti-tumor efficacy of NK cells
Jeremiah L. Oyer, Sarah B. Gitto, Deborah A. Altomare, et al.
OncoImmunology (2018) Vol. 7, Iss. 11
Open Access | Times Cited: 132
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy
Heleen Dewitte, Sandra Van Lint, Carlo Heirman, et al.
Journal of Controlled Release (2014) Vol. 194, pp. 28-36
Open Access | Times Cited: 107
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy
Hyunjoon Kim, Drishti Sehgal, Tamara A. Kucaba, et al.
Nanoscale (2018) Vol. 10, Iss. 44, pp. 20851-20862
Closed Access | Times Cited: 68
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
Congcong Zhang, Jasmin Röder, Anne Scherer, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e002980-e002980
Open Access | Times Cited: 47
Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions
Simone Battella, Maria Christina Cox, Angela Santoni, et al.
Journal of Leukocyte Biology (2015) Vol. 99, Iss. 1, pp. 87-96
Open Access | Times Cited: 60
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner
Sébastien Anguille, Heleen H. Van Acker, Johan van den Bergh, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0123340-e0123340
Open Access | Times Cited: 56
NK Cells Help Induce Anti–Hepatitis B Virus CD8+ T Cell Immunity in Mice
Meijuan Zheng, Rui Sun, Haiming Wei, et al.
The Journal of Immunology (2016) Vol. 196, Iss. 10, pp. 4122-4131
Open Access | Times Cited: 55
Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
Long‐Bin Jeng, Li‐Ying Liao, Fu‐Ying Shih, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4380-4380
Open Access | Times Cited: 23
NK cell education: Physiological and pathological influences
Philippe Rascle, Griffin Woolley, Stéphanie Jost, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma
Yusuke Sato, Kanako Shimizu, Jun Shinga, et al.
OncoImmunology (2015) Vol. 4, Iss. 3, pp. e995541-e995541
Open Access | Times Cited: 48
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity
Johan van den Bergh, Yannick Willemen, Eva Lion, et al.
Oncotarget (2015) Vol. 6, Iss. 42, pp. 44123-44133
Open Access | Times Cited: 47
Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity
Moon Hee Lee, Jong‐Hwa Jang, Gun Young Yoon, et al.
BMB Reports (2017) Vol. 50, Iss. 5, pp. 263-268
Open Access | Times Cited: 41
Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination
Jasper J. P. van Beek, Florian Wimmers, Stanleyson V. Hato, et al.
Critical Reviews in Immunology (2014) Vol. 34, Iss. 6, pp. 517-536
Open Access | Times Cited: 41
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
Tammy Oth, Joris Vanderlocht, Catharina H. M. J. Van Elssen, et al.
Mediators of Inflammation (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 33
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
Sara Pessina, Gabriele Cantini, Dimos Kapetis, et al.
OncoImmunology (2015) Vol. 5, Iss. 5, pp. e1108513-e1108513
Open Access | Times Cited: 31
Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients
Luciano Castiello, Marianna Sabatino, Jiaqiang Ren, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 13, pp. 3352-3364
Open Access | Times Cited: 30
Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
Cao Dai Phung, Tuan Hiep Tran, Jong Oh Kim
Archives of Pharmacal Research (2020) Vol. 43, Iss. 1, pp. 32-45
Closed Access | Times Cited: 26
NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
Caterina Lapenta, Simona Donati, Francesca Spadaro, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 3, pp. 795-806
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top